These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 9366578

  • 1. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand.
    Georgescu L, Vakkalanka RK, Elkon KB, Crow MK.
    J Clin Invest; 1997 Nov 15; 100(10):2622-33. PubMed ID: 9366578
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
    Suzuki N, Ichino M, Mihara S, Kaneko S, Sakane T.
    Arthritis Rheum; 1998 Feb 15; 41(2):344-53. PubMed ID: 9485093
    [Abstract] [Full Text] [Related]

  • 3. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H, Xu J, Ji X, Yang X, Sun K, Liu X, Shen Y.
    Cell Immunol; 2005 Jun 15; 235(2):117-21. PubMed ID: 16226734
    [Abstract] [Full Text] [Related]

  • 4. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.
    Lorenz HM, Grünke M, Hieronymus T, Herrmann M, Kühnel A, Manger B, Kalden JR.
    Arthritis Rheum; 1997 Feb 15; 40(2):306-17. PubMed ID: 9041943
    [Abstract] [Full Text] [Related]

  • 5. Role of IL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus.
    González-Amaro R, Portales-Pérez D, Baranda L, Abud-Mendoza C, Llorente L, Richaud-Patin Y, Alcocer-Varela J, Alarcón-Segovia D.
    J Autoimmun; 1998 Oct 15; 11(5):395-402. PubMed ID: 9802922
    [Abstract] [Full Text] [Related]

  • 6. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb 15; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 7. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM, Taher TE, Isenberg DA, Mageed RA.
    Scand J Rheumatol; 2009 Feb 15; 38(2):112-20. PubMed ID: 19110660
    [Abstract] [Full Text] [Related]

  • 8. [Studies on Fas ligand expression in patients with systemic lupus erythematosus].
    Feng Y.
    Hokkaido Igaku Zasshi; 1997 Jul 15; 72(4):443-55. PubMed ID: 9266252
    [Abstract] [Full Text] [Related]

  • 9. Hyporesponsiveness to gammac-chain cytokines in activated lymphocytes from patients with systemic lupus erythematosus leads to accelerated apoptosis.
    Lorenz HM, Grünke M, Hieronymus T, Winkler S, Blank N, Rascu A, Wendler J, Geiler T, Kalden JR.
    Eur J Immunol; 2002 May 15; 32(5):1253-63. PubMed ID: 11981812
    [Abstract] [Full Text] [Related]

  • 10. Fas ligand expression and function in systemic lupus erythematosus.
    McNally J, Yoo DH, Drappa J, Chu JL, Yagita H, Friedman SM, Elkon KB.
    J Immunol; 1997 Nov 01; 159(9):4628-36. PubMed ID: 9379065
    [Abstract] [Full Text] [Related]

  • 11. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus.
    Tsai HF, Lai JJ, Chou AH, Wang TF, Wu CS, Hsu PN.
    Arthritis Rheum; 2004 Feb 01; 50(2):629-39. PubMed ID: 14872508
    [Abstract] [Full Text] [Related]

  • 12. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M, van Lopik T, Limburg PC, Spronk PE, Jaegers SM, Aarden LA, Smeenk RJ, Kallenberg GG.
    J Autoimmun; 1998 Oct 01; 11(5):457-63. PubMed ID: 9802929
    [Abstract] [Full Text] [Related]

  • 13. Fas (CD95)-transduced signal preferentially stimulates lupus peripheral T lymphocytes.
    Sakata K, Sakata A, Vela-Roch N, Espinosa R, Escalante A, Kong L, Nakabayashi T, Cheng J, Talal N, Dang H.
    Eur J Immunol; 1998 Sep 01; 28(9):2648-60. PubMed ID: 9754553
    [Abstract] [Full Text] [Related]

  • 14. Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus.
    Kovacs B, Liossis SN, Dennis GJ, Tsokos GC.
    Autoimmunity; 1997 Sep 01; 25(4):213-21. PubMed ID: 9344329
    [Abstract] [Full Text] [Related]

  • 15. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH, Zhang J, Cai Q, Zhao DB, Wang J, Guo PE, Liu L, Han XH, Shen Q.
    Rheumatology (Oxford); 2005 Oct 01; 44(10):1245-54. PubMed ID: 15987711
    [Abstract] [Full Text] [Related]

  • 16. Impaired cytotoxic T lymphocyte activity in systemic lupus erythematosus following in vitro polyclonal T cell stimulation: a contributory role for non-T cells.
    Stohl W, Hamilton AS, Deapen DM, Mack TM, Horwitz DA.
    Lupus; 1999 Oct 01; 8(4):293-9. PubMed ID: 10413208
    [Abstract] [Full Text] [Related]

  • 17. Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera.
    Matsuno H, Yudoh K, Nakazawa F, Sawai T, Uzuki M, Nishioka K, Yonehara S, Nakayama J, Ohtsuki M, Kimura T.
    J Rheumatol; 2002 Aug 01; 29(8):1609-14. PubMed ID: 12180717
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients.
    Lauwerys BR, Garot N, Renauld JC, Houssiau FA.
    Arthritis Rheum; 2000 Sep 01; 43(9):1976-81. PubMed ID: 11014347
    [Abstract] [Full Text] [Related]

  • 19. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
    Chen DY, Hsieh TY, Hsieh CW, Lin FJ, Lan JL.
    Arthritis Rheum; 2007 Dec 15; 57(8):1530-8. PubMed ID: 18050226
    [Abstract] [Full Text] [Related]

  • 20. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus.
    Gergely P, Niland B, Gonchoroff N, Pullmann R, Phillips PE, Perl A.
    J Immunol; 2002 Jul 15; 169(2):1092-101. PubMed ID: 12097418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.